Author

Laura Radić

Amsterdam University Medical CentersORCID 0000-0002-6516-0123Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Microbiology· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 2 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Janke SchinkeliD· 3 shared Kwinten SliepeniD· 3 shared Rogier W. SandersiD· 3 shared Andrew B. WardiD· 2 shared Fabian MulderiD· 2 shared Ian ZoniD· 2 shared Joan Capella-PujoliD· 2 shared Marit J. van GilsiD· 2 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 43 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

Janke SchinkelORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Consensus native-like hepatitis C virus E1E2 engages broadly neutralizing antibody precursors

Fabian Mulder, Fabien Cannac, Joan Capella-Pujol, Stan Peters, Meliawati Poniman, Wouter Olijhoek, Luke A. Granger, Marco Antonio Briones-Orta, Kostas Paschos, Sophie van der Pol, Ruben Walen, Maddy L. Newby, Wen-Hsin Lee, Laura Radić, Ian Zon, , Kwinten Sliepen

This paper develops a consensus HCV E1E2 antigen that engages germline B cell precursors of broadly neutralizing antibodies.

bioRxiv · Aug 26, 2026 · PreprintImmunology

Bispecific antibodies against the hepatitis C virus E1E2 envelope glycoprotein

Laura Radić, Anna Offersgaard, Tereza Kadavá, Ian Zon, Joan Capella-Pujol, Fabian Mulder, Sylvie M. Koekkoek, Vera Spek, Ana Chumbe, Jens Bukh, Marit J. van Gils, Rogier W. Sanders, Victor C. Yin, Albert J. R. Heck, Judith M. Gottwein, , Janke Schinkel

This study generates bispecific antibodies targeting two distinct HCV E1E2 epitopes, showing enhanced neutralization breadth and potency compared to monospecific antibodies.

Proceedings of the National Academy of Sciences · Apr 7, 2025Peer-reviewedMicrobiology

Broadening sarbecovirus neutralization with bispecific antibodies combining distinct conserved targets on the receptor binding domain

Denise Guerra, Laura Radić, Mitch Brinkkemper, Meliawati Poniman, Lara van der Maas, Jonathan L. Torres, Andrew B. Ward, Kwinten Sliepen, Janke Schinkel, Rogier W. Sanders, Marit J. van Gils, Tim Beaumont

This study develops bispecific antibodies that target conserved regions on the SARS-CoV-2 spike protein, showing improved neutralization breadth against multiple sarbecovirus strains.

Human Vaccines & Immunotherapeutics · Aug 20, 2024Peer-reviewedMicrobiology